DRIP1 Polyclonal Antibody, Biotin Conjugated
Product Specifications
Background
1.C14ORF28, GNB2L1, MLLT3, DRD2 and DARPP-32 are important in the pathogenesis of schizophrenia and bipolar disorder; 2. these two disorders share common disease-related mechanisms linked to dopamine signalling; 3. the expression of these genes is closely correlated; and 4. DRD2 provides the initial trigger in the pathogenesis of these disorders.
Synonyms
CN028_HUMAN; Dopamine receptor interacting protein 1; Dopamine receptor-interacting protein 1; DRIP 1; DRIP1; Uncharacterized protein C14orf28; C14orf28.
Gene ID
122525
Host
Rabbit
Cross Reactivity
Human, Mouse, Rat
Immunogen
31-130/310
Target
DRIP1
Clonality
Polyclonal
Isotype
IgG
Conjugation
Biotin
Source
KLH conjugated synthetic peptide derived from human DRIP1/C14orf28
Applications
WB, IHC-P
Purification
Purified by Protein A.
Concentration
1µg/µl
Dilution
WB (1:300-5000), IHC-P (1:200-400)
Buffer
Aqueous buffered solution containing 0.01M TBS (pH 7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
Modification
Unmodified
Storage Conditions
Store at -20°C for 12 months.
Gene ID URL
122525
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
165236 50 mg
N-[3-[[4- (Chloromethyl) benzoyl]amino][1,1'-biphenyl]-4-yl]carbamic Acid tert-Butyl Ester
Ask
View Details